15 December 1995 | Volume 123 Issue 12 | Pages 919-924
Objective: To determine basal levels of cytosolic calcium ([Ca2+]i) and phagocytic activity in polymorphonuclear leukocytes (PMNLs) from patients with non-insulin-dependent diabetes (NIDDM).
Design: Prospective cohort study.
Setting: A university-county hospital.
Measurements: Cytosolic calcium levels, adenosine triphosphate (ATP) content, and phagocytosis of PMNLs from patients with NIDDM and from controls.
Intervention: In patients with NIDDM, we evaluated the effect of treatment with an oral hypoglycemic agent (glyburide) on [Ca2+]i levels, ATP content, and the phagocytosis of PMNLs.
Patients: 22 controls and 34 patients with NIDDM were examined. Fifteen patients were studied before and after 3 months of treatment with glyburide.
Results: Polymorphonuclear leukocytes from patients with NIDDM showed significantly elevated basal levels of [Ca2+]i (68 ± 9.6 compared with 43 ± 4.9 nmol/L; P < 0.01); reduced ATP content (1.30 ± 0.58 compared with 2.35 ± 0.45 nmol/106PMNLs; P < 0.01); and impaired phagocytosis (117 ± 21.0 compared with 145 ± 17.4 µg oil/107PMNLs per minute; P < 0.01) compared with controls. There was a direct and significant correlation (P < 0.01, r = 0.80) between [Ca2+]i levels in PMNLs and serum glucose levels and an inverse correlation between phagocytic ability and [Ca2+]i levels (P < 0.01; r = 0.62) as well as between phagocytic activity and fasting serum glucose levels (P < 0.01, r = 0.54) in patients with NIDDM. Glyburide therapy resulted in significant reduction in fasting serum glucose levels; in PMNLs, this treatment resulted in a significant reduction in [Ca2+]i levels, a significant increase in ATP content, and a significant improvement of phagocytosis.
Conclusions: Patients with NIDDM have elevated [Ca2+]i levels in PMNLs. This abnormality is probably induced by hyperglycemia and is primarily responsible for the impaired phagocytosis seen in these patients.
Author and Article Information
From the University of Southern California School of Medicine, Los Angeles, California.
ARTICLE
Polymorphonuclear Leukocytes in Non-Insulin-dependent Diabetes Mellitus: Abnormalities in Metabolism and Function
![]()
Grant Support: By National Institute of Diabetes and Digestive and Kidney Diseases grant DK 29955. Dr. Klin was supported by the Fogarty International Fellowship.
Request for Reprints: Shaul G. Massry, MD, Chief, Division of Nephrology, University of Southern California School of Medicine, 2025 Zonal Avenue, Los Angeles, CA 90033.
Current Author Addresses: Drs. Alexiewicz, Smogorzewski, Klin, and Massry: Division of Nephrology, University of Southern California School of Medicine, 2025 Zonal Avenue, Los Angeles, CA 90033.
Dr. Kumar: Division of Endocrinology, Diabetes and Hypertension, University of Southern California School of Medicine, 2025 Zonal Avenue, Los Angeles, CA 90033.
Related articles in Annals:
This article has been cited by other articles:
![]() |
A. Farooki and S. H. Schneider Insulin Resistance and Cancer-Related Mortality J. Clin. Oncol., April 20, 2007; 25(12): 1628 - 1629. [Full Text] [PDF] |
||||
![]() |
S. Clement, S. S. Braithwaite, M. F. Magee, A. Ahmann, E. P. Smith, R. G. Schafer, and I. B. Hirsch Management of Diabetes and Hyperglycemia in Hospitals Diabetes Care, February 1, 2004; 27(2): 553 - 591. [Full Text] [PDF] |
||||
![]() |
B. R. Shah and J. E. Hux Quantifying the Risk of Infectious Diseases for People With Diabetes Diabetes Care, February 1, 2003; 26(2): 510 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Rassias, A. L. Givan, C. A. S. Marrin, K. Whalen, J. Pahl, and M. P. Yeager Insulin Increases Neutrophil Count and Phagocytic Capacity After Cardiac Surgery Anesth. Analg., May 1, 2002; 94(5): 1113 - 1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. McManus, R. C. Bloodworth, T. J. Prihoda, J. L. Blodgett, and R. N. Pinckard Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia J. Leukoc. Biol., September 1, 2001; 70(3): 395 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Krause, S. Patruta, F. Daxbock, P. Fladerer, and C. Wenisch The effect of fosfomycin on neutrophil function J. Antimicrob. Chemother., February 1, 2001; 47(2): 141 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shurtz-Swirski, S. Sela, A. T. Herskovits, S. M. Shasha, G. Shapiro, L. Nasser, and B. Kristal Involvement of Peripheral Polymorphonuclear Leukocytes in Oxidative Stress and Inflammation in Type 2 Diabetic Patients Diabetes Care, January 1, 2001; 24(1): 104 - 110. [Abstract] [Full Text] |
||||
![]() |
G. Caimi, F. Ferrara, M. Montana, F. Meli, B. Canino, C. Carollo, and R. L. Presti Acute Ischemic Stroke : Polymorphonuclear Leukocyte Membrane Fluidity and Cytosolic Ca2+ Concentration at Baseline and After Chemotactic Activation Stroke, July 1, 2000; 31(7): 1578 - 1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Wright, F. N. Nwariaku, J. Clark, J. C. Falck, T. Rogers, and R. H. Turnage Effect of Diabetes Mellitus on Endotoxin-Induced Lung Injury Arch Surg, December 1, 1999; 134(12): 1354 - 1359. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Goetz and R. A. Proctor Normalization of Intracellular Calcium: A Sweet Solution to Neutrophil Dysfunction in Diabetes? Ann Intern Med, December 15, 1995; 123(12): 952 - 954. [Full Text] |
||||